
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA (FMS) Cash on Hand — Cash & Short-Term Investments
Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.
FMS · cash on hand · updated Dec 31, 2025
Core cash position
as of Dec 31, 2025Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.
Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in EUR
Net cash vs debt
Cash vs Debt · Balance Sheet HealthFresenius Medical Care AG & Co. KGaA carries a net debt position of $9.20B. Total debt ($10.79B) exceeds cash on hand ($1.60B). Fresenius Medical Care AG & Co. KGaA cash vs debt ratio: 13% cash / 87% debt.
Cash on hand history
Annual cash on hand by year
FMS cash & short-term investments historyHealthcare Sector Cash Reserves Comparison
About cash on hand & methodology
Fresenius Medical Care AG & Co. KGaA (FMS) cash on hand as of December 31, 2025 is $1.60B, comprising $1.60B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Fresenius Medical Care AG & Co. KGaA cash and short-term investments on the balance sheet (10-K filing). Also referred to as Fresenius Medical Care AG & Co. KGaA cash reserves or cash position.
Fresenius Medical Care AG & Co. KGaA annual cash on hand history shows increased +19.0% in 2025: increased +19.0% in 2025. Fresenius Medical Care AG & Co. KGaA cash reserves in 2025 reflect the company's capital allocation strategy.
Fresenius Medical Care AG & Co. KGaA carries total debt of $10.79B against cash of $1.60B, resulting in a net debt position of -$9.20B. For the full balance sheet, see the Financials → Balance Sheet tab.
Frequently asked questions
FMS cash on hand · 5 questionsAs of December 31, 2025, Fresenius Medical Care AG & Co. KGaA (FMS) has $1.60B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1.60B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $1.62B. Data sourced from the annual 10-K filing via FMP.
▸ Source: FMP /balance-sheet-statement · US GAAP · Fresenius Medical Care AG & Co. KGaA · Fresenius Medical Care AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025